Clinical Trial Update: An Exploratory Study to Evaluate the Efficacy and Safety of FCN-159 in Patients With Brain Arteriovenous Malformations [Phase 2]

View source ↗

Summary

This is a Phase 2 exploratory trial evaluating the efficacy and safety of FCN-159 in patients with brain arteriovenous malformations. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Arteriovenous Malformation

Drugs mentioned

• FCN-159

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Brain Arteriovenous Malformations | Phase 2 | Status: RECRUITING